Berlin, Germany

R Thieroff-Ekerdt

This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: R Thieroff-Ekerdt. Retrieved from https://idiyas.com/inventor/r-thieroff-ekerdt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: R Thieroff-Ekerdt: Innovator in Vitamin D Derivatives

Introduction

R Thieroff-Ekerdt is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of vitamin D derivatives, showcasing his expertise and innovative spirit. His work has led to the development of new compounds that could have important implications in various applications.

Latest Patents

Thieroff-Ekerdt holds a patent for "24-Oxa derivatives in the vitamin D series." This patent describes new 24-oxa derivatives of vitamin D, which are characterized by a general formula I. The innovation represented in this patent highlights his commitment to advancing scientific knowledge and practical applications in the field of vitamin D.

Career Highlights

Throughout his career, Thieroff-Ekerdt has been associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Schering has allowed him to collaborate with other talented professionals and contribute to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Andreas Steinmeyer and Katica Schwarz. Their collaborative efforts have likely played a role in the successful development of innovative products and research initiatives.

Conclusion

R Thieroff-Ekerdt's contributions to the field of vitamin D derivatives exemplify the impact of dedicated inventors in advancing scientific research. His patent and work at Schering Aktiengesellschaft reflect a commitment to innovation and collaboration in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…